The Europe viscosupplementation market is projected to expand from USD 523.9 million in 2025 to USD 869.8 million by 2035, registering a steady 5.2% CAGR during the forecast period. This growth is being driven by the rising prevalence of osteoarthritis, demographic aging, and the growing preference for non-surgical joint therapies. The Europe viscosupplementation market is …